Diversify Advisory Services LLC Makes New $1.52 Million Investment in Cigna Group $CI

Diversify Advisory Services LLC bought a new stake in Cigna Group (NYSE:CIFree Report) during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 5,230 shares of the health services provider’s stock, valued at approximately $1,522,000.

Other institutional investors have also recently made changes to their positions in the company. Norges Bank purchased a new position in shares of Cigna Group during the 4th quarter worth about $1,019,790,000. Northwestern Mutual Wealth Management Co. raised its position in Cigna Group by 13,333.2% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 3,165,408 shares of the health services provider’s stock worth $900,912,000 after purchasing an additional 3,141,844 shares during the period. Dodge & Cox lifted its stake in Cigna Group by 19.7% in the fourth quarter. Dodge & Cox now owns 11,138,614 shares of the health services provider’s stock worth $3,065,681,000 after purchasing an additional 1,833,389 shares during the last quarter. Boston Partners boosted its position in shares of Cigna Group by 314.6% during the fourth quarter. Boston Partners now owns 1,638,191 shares of the health services provider’s stock valued at $450,856,000 after buying an additional 1,243,056 shares during the period. Finally, GQG Partners LLC grew its stake in shares of Cigna Group by 14.3% during the fourth quarter. GQG Partners LLC now owns 7,763,295 shares of the health services provider’s stock valued at $2,136,699,000 after buying an additional 972,302 shares during the last quarter. Institutional investors own 86.99% of the company’s stock.

Cigna Group Price Performance

NYSE CI opened at $277.36 on Thursday. The firm’s fifty day simple moving average is $285.03 and its two-hundred day simple moving average is $281.41. The firm has a market capitalization of $73.29 billion, a P/E ratio of 11.48, a P/E/G ratio of 0.96 and a beta of 0.29. The company has a current ratio of 0.76, a quick ratio of 0.76 and a debt-to-equity ratio of 0.68. Cigna Group has a 12-month low of $239.51 and a 12-month high of $315.47.

Cigna Group (NYSE:CIGet Free Report) last issued its quarterly earnings data on Thursday, July 30th. The health services provider reported $7.78 EPS for the quarter, beating the consensus estimate of $7.60 by $0.18. The firm had revenue of $70.04 billion during the quarter, compared to analyst estimates of $70.14 billion. Cigna Group had a return on equity of 19.75% and a net margin of 2.27%.During the same quarter in the prior year, the business posted $7.20 EPS. The business’s revenue for the quarter was up 6.7% compared to the same quarter last year. Cigna Group has set its FY 2026 guidance at 30.450- EPS. Analysts forecast that Cigna Group will post 30.51 EPS for the current fiscal year.

Cigna Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, September 23rd. Stockholders of record on Tuesday, September 8th will be paid a dividend of $1.56 per share. The ex-dividend date is Tuesday, September 8th. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.2%. Cigna Group’s payout ratio is presently 25.82%.

Insider Activity

In related news, insider Nicole S. Jones sold 19,436 shares of the stock in a transaction that occurred on Tuesday, August 4th. The shares were sold at an average price of $276.27, for a total value of $5,369,583.72. Following the completion of the transaction, the insider directly owned 27,256 shares of the company’s stock, valued at $7,530,015.12. This trade represents a 41.63% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Jamie G. Kates sold 899 shares of Cigna Group stock in a transaction that occurred on Friday, June 12th. The stock was sold at an average price of $298.61, for a total transaction of $268,450.39. Following the completion of the sale, the chief accounting officer owned 2,368 shares of the company’s stock, valued at $707,108.48. This trade represents a 27.52% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Corporate insiders own 0.60% of the company’s stock.

Wall Street Analysts Forecast Growth

CI has been the topic of a number of recent analyst reports. Weiss Ratings reiterated a “hold (c)” rating on shares of Cigna Group in a research note on Monday, June 1st. Deutsche Bank Aktiengesellschaft cut shares of Cigna Group from a “buy” rating to a “hold” rating and dropped their target price for the stock from $303.00 to $302.00 in a report on Wednesday, May 20th. Barclays boosted their price target on shares of Cigna Group from $304.00 to $310.00 and gave the company an “equal weight” rating in a report on Friday, July 31st. Raymond James Financial cut shares of Cigna Group from a “strong-buy” rating to an “outperform” rating and lowered their price target for the stock from $350.00 to $320.00 in a research report on Monday, August 3rd. Finally, Wolfe Research reiterated an “outperform” rating and set a $315.00 price objective on shares of Cigna Group in a research note on Tuesday, June 16th. Fifteen equities research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $339.45.

Check Out Our Latest Report on Cigna Group

About Cigna Group

(Free Report)

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

Further Reading

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CIFree Report).

Institutional Ownership by Quarter for Cigna Group (NYSE:CI)

Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.